IVIG for Infection Prevention After CAR-T-Cell Therapy

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(7 sites)

United States

City of Hope Cancer Center, Duarte, California

University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida

Moffitt Cancer Center, Tampa, Florida

Massachusetts General Hospital Cancer Center, Boston, Massachusetts

Memorial Sloan Kettering Cancer Center, New York, New York

Oregon Health and Science University (OHSU) Knight Cancer Institute, Portland, Oregon

Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington